论文部分内容阅读
目的:观察益气活血中药治疗晚期非小细胞肺癌的临床疗效。方法:将98例晚期非小细胞肺癌患者随机分为2组,对照组48例采用NP方案治疗,治疗组50例在对照组治疗基础上,于化疗开始前3天口服益气活血中药。2组均治疗2疗程后评价疗效。结果:2组近期疗效、临床症状改善情况、生存质量问卷、呼吸频率比较,差异均有显著性意义(P<0.05);治疗后卡氏评分2组比较,差异有非常显著性意义(P<0.01);治疗后2组体重比较,差异无显著性意义(P>0.05)。结论:益气活血中药治疗晚期非小细胞肺癌疗效肯定。
Objective: To observe the clinical curative effect of Yiqi Huoxue Chinese medicine in the treatment of advanced non-small cell lung cancer. Methods: Ninety-eight patients with advanced non-small cell lung cancer were randomly divided into two groups. 48 patients in the control group were treated with NP regimen. 50 patients in the treatment group received Yiqi Huoxue Chinese medicine 3 days before the start of chemotherapy based on the treatment of the control group. Two groups were treated after 2 courses to evaluate the curative effect. Results: There were significant differences between the two groups in short-term curative effect, clinical symptom improvement, quality of life questionnaire and respiratory rate (P <0.05). There was significant difference between the two groups after treatment (P < 0.01). There was no significant difference in body weight between the two groups after treatment (P> 0.05). Conclusion: Yiqihuoxue Chinese medicine treatment of advanced non-small cell lung cancer is sure.